SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549

                                    FORM 10-Q


                 QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934




For Quarter Ended                 April 29, 2000
                  -----------------------------------------------
Commission File Number                0-3319
                      -------------------------------------------



                          DEL GLOBAL TECHNOLOGIES CORP.
                          -----------------------------
             (Exact name of registrant as specified in its charter)

          New York                                               13-1784308
-------------------------------                              -------------------
(State or other jurisdiction of                               (I.R.S. Employer
incorporation or organization)                               Identification No.)

                      One Commerce Park, Valhalla, NY 10595
--------------------------------------------------------------------------------
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (914) 686-3600
                                 --------------
               (Registrant's telephone number including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

Yes   X                No
   -------

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the close of the business on June 15, 2000.

                            Common Stock - 7,861,379




<PAGE>





                                     PART I


Item 1.  Financial Statements

              Consolidated Balance Sheets - April 29, 2000 and July 31, 1999

              Consolidated  Statements  of Income for the Three  Months and Nine
              Months Ended April 29, 2000 and May 1, 1999

              Consolidated Statements of Cash Flows for the Nine Months Ended
              April 29, 2000 and May 1, 1999

              Notes to Consolidated Financial Statements

                                       -1-


<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS

                                   (Unaudited)

                                      ASSETS
                                                     April 29,        July 31,
                                                       2000             1999
                                                   ------------     ------------

CURRENT ASSETS
        Cash and cash equivalents                  $  1,167,532     $    320,742
        Investments available-for-sale                1,302,641        1,292,852
        Trade receivables - net                      23,722,438       15,624,433
        Cost and estimated earnings
           in excess of billings on
           uncompleted contracts                      9,674,098        6,402,532
        Inventory                                    42,747,539       36,599,587
        Prepaid expenses and other
           current assets                             2,574,811        1,216,145
                                                   ------------     ------------
             Total current assets                    81,189,059       61,456,291
                                                   ------------     ------------

FIXED ASSETS - Net                                   15,684,603       14,668,060
INTANGIBLES - Net                                       742,775          879,898
GOODWILL - Net                                        7,562,886        5,236,965
OTHER ASSETS                                          2,030,006        1,862,743
                                                   ------------     ------------
        TOTAL                                      $107,209,329     $ 84,103,957
                                                   ============     ============

                      LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES
         Notes payable - banks                    $   3,313,444    $        --
         Current portion of long-term debt            1,571,153          516,654
         Accounts payable - trade                    11,174,802        6,295,586
         Accrued liabilities                          5,744,752        4,468,521
         Deferred compensation liability              1,916,331        1,201,065
         Income taxes                                 1,375,180        1,224,451
                                                  -------------    -------------
              Total current liabilities              25,095,662       13,706,277
                                                  -------------    -------------

LONG-TERM LIABILITIES
         Long-term debt (less current portion)        6,136,615        1,832,287
         Other                                        2,181,040          594,272
         Deferred income taxes                        2,057,186        1,620,417
                                                  -------------    -------------
              Total liabilities                      35,470,503       17,753,253
                                                  -------------    -------------

MINORITY INTEREST IN SUBSIDIARY                          28,350             --
                                                  -------------    -------------

SHAREHOLDERS' EQUITY
         Common stock, $.10 par value;
            Authorized 20,000,000 shares;
            Issued and outstanding - $8,402,245
            shares at April 29, 2000 and
            8,278,646 shares at July 31, 1999           840,226          827,866
         Additional paid-in capital                  51,594,965       50,798,502
         Comprehensive income                            (8,091)            --
         Retained earnings                           24,250,499       19,032,506
                                                  -------------    -------------
                                                     76,677,599       70,658,874
         Less common stock in treasury -
            572,346 shares at April 29, 2000
            and 490,393 shares at July 31, 1999       4,967,123        4,308,170
                                                  -------------    -------------
                    Total shareholders' equity       71,710,476       66,350,704
                                                  -------------    -------------
         TOTAL                                    $ 107,209,329    $  84,103,957
                                                  =============    =============

   See notes to consolidated financial statements


                                       -2-


<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                        CONSOLIDATED STATEMENTS OF INCOME

                                   (Unaudited)

                                 Three Months Ended        Nine Months Ended
                              ------------------------  ------------------------
                               April 29,     May 1,      April 29,     May 1,
                                 2000         1999         2000         1999
                              -----------  -----------  -----------  -----------
NET SALES                     $20,526,198  $18,684,525  $53,688,571  $49,416,143
                              -----------  -----------  -----------  -----------
COSTS AND EXPENSES:
     Cost of sales             12,527,706   11,216,870   32,257,905   29,204,291
     Research and development   2,052,124    1,753,406    5,301,967    4,707,649
     Selling, general and
        administrative          2,990,150    3,064,658    8,294,113    8,435,479
     Interest expense - net       128,941       78,577      274,073      101,289
                              -----------  -----------  -----------  -----------
                               17,698,921   16,113,511   46,128,058   42,448,708
                              -----------  -----------  -----------  -----------
INCOME BEFORE PROVISION
     FOR INCOME TAXES AND
     MINORITY INTEREST          2,827,277    2,571,014    7,560,513    6,967,435

PROVISION FOR INCOME TAXES        886,827      797,015    2,325,922    2,159,905
                              -----------  -----------  -----------  -----------
NET INCOME BEFORE MINORITY
     INTEREST                   1,940,450    1,773,999    5,234,591    4,807,530
MINORITY INTEREST                  16,598         --         16,598         --
                              -----------  -----------  -----------  -----------
NET INCOME                    $ 1,923,852  $ 1,773,999  $ 5,217,993  $ 4,807,530
                              ===========  ===========  ===========  ===========

NET INCOME PER COMMON
     SHARE AND COMMON

     BASIC                    $       .25  $       .23  $       .67  $       .63
                              ===========  ===========  ===========  ===========
     DILUTED                  $       .24  $       .22  $       .64  $       .59
                              ===========  ===========  ===========  ===========

Weighted average number
     of common shares
     outstanding                7,824,196    7,700,294    7,807,739    7,658,666
                              ===========  ===========  ===========  ===========
Weighted average number
     of common shares
     outstanding and common
     share equivalents          8,175,899    8,163,269    8,170,552    8,163,470
                              ===========  ===========  ===========  ===========

  See notes to consolidated financial statements


                                       -3-


<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (Unaudited)

                                                          Nine Months Ended
                                                      -------------------------
                                                       April 29,       May 1,
                                                         2000           1999
                                                      -----------   -----------
CASH FLOWS FROM OPERATING ACTIVITIES:
   Net Income                                         $ 5,217,993   $ 4,807,530
   Adjustments to reconcile net
   income to net cash provided by
   operating activities:
      Depreciation                                      1,779,856     1,287,436
      Amortization                                        567,385       508,615
      Imputed interest                                     49,471        62,986
      Deferred income tax provision                       410,204       192,547
      Tax benefit from exercise of stock
          options and warrants                            252,770       450,530
      Amortization of stock-based compensation             39,218        16,822
      Minority interest in net income of
         consolidated subsidiary                           16,598          --
      Changes in assets and liabilities
      (net of acquisition of subsidiary):
         Increase in trade receivables                 (1,136,875)   (1,585,932)
         Increase in cost and estimated earnings
            in excess of billings on uncompleted
            contracts                                  (3,271,566)   (2,134,867)
         Increase in inventory                         (1,768,587)   (5,290,759)
         Increase in prepaid and other current
            assets                                     (1,018,292)   (1,014,802)
         Increase in other assets                        (206,031)      (22,875)
         Increase in accounts payable - trade             434,113     1,612,833
         (Decrease) increase in accrued liabilities      (142,937)      584,712
         Increase in deferred compensation liability      215,128       260,703
         Increase in income taxes payable                 460,592     1,042,273
                                                      -----------   -----------
           Net cash provided by operating activities    1,899,040       777,752
                                                      -----------   -----------

CASH FLOWS FROM INVESTING ACTIVITIES:
      Net cash paid to acquire subsidiary              (1,099,027)     (550,018)
      Expenditures for fixed assets                    (2,362,128)   (2,412,838)
      Investment in marketable securities                  (9,789)     (114,459)
      Payments to former shareholders of subsidiary
         acquired                                         (65,096)     (119,569)
                                                      -----------   -----------
           Net cash used in investing activities       (3,536,040)   (3,196,884)
                                                      -----------   -----------

CASH FLOWS FROM FINANCING ACTIVITIES:
      Net proceeds from bank borrowing                  2,912,777       653,399
      Payment for repurchase of shares                   (549,471)   (1,130,251)
      Proceeds from exercise of stock options
         and warrants                                     138,651       448,498
      Other                                               (18,167)       (2,067)
                                                      -----------   -----------
           Net cash provided by (used in) financing
              activities                                2,483,790       (30,421)
                                                      -----------   -----------

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS      846,790    (2,449,553)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD            320,742     3,401,697
                                                      -----------   -----------

CASH AND CASH EQUIVALENTS, END OF PERIOD              $ 1,167,532   $   952,144
                                                      ===========   ===========

  See notes to consolidated financial statements



                                       -4-


<PAGE>






                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (Unaudited)

                                                          Nine Months Ended
                                                      -------------------------
                                                        April 29,      May 1,
                                                          2000          1999
                                                      -----------   -----------

SUPPLEMENTAL DISCLOSURES OF CASH FLOW
   INFORMATION:

   Interest paid                                     $    227,748  $    142,395
                                                     ============  ============
   Income taxes paid                                 $  1,191,320  $    473,940
                                                     ============  ============


SUPPLEMENTAL SCHEDULE OF INVESTING AND
   FINANCING ACTIVITIES:

   Investment in subsidiary                          $  2,543,867
   Less cash acquired                                  (1,214,539)
   Compensation cost of warrant issued                   (218,702)
   Investment costs in accrued expenses                   (11,599)
                                                     -------------
   Net cash paid to acquire subsidiary               $  1,099,027
                                                     ============

   Acquisition of selected assets                                  $  1,508,702
   Payment due under acquisition term note                             (958,684)
                                                                   ------------
   Net cash paid to acquire selected assets                        $    550,018
                                                                   ============






  See notes to consolidated financial statements









                                       -5-


<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                                 (Unaudited)

NOTE 1         In  the  opinion  of  management,   the  accompanying   unaudited
               consolidated   financial   statements   contain  all  adjustments
               (consisting of only normal  recurring  adjustments)  necessary to
               present fairly the results of the Company's financial position as
               of April 29, 2000 and the results of its  operations and its cash
               flows for the nine months ended April 29, 2000 and May 1, 1999.

               The Company's  consolidated  financial statements,  in conformity
               with  generally  accepted  accounting  principles,   include  the
               assets,  liabilities  and the results of operations of a majority
               owned subsidiary. The ownership  of the other interest holders is
               reflected as minority interest.

               The accounting  policies followed by the Company are set forth in
               Note 1 to the Company's financial statements as of July 31, 1999.

               The financial  statements of the consolidated  foreign subsidiary
               Villa  Sistemi  Medicali  S.p.A.  ("Villa")  are  denominated  in
               Italian lira and are  converted  into U.S.  dollars for reporting
               purposes.  As a  result,  they  are  subject  to the  effects  of
               currency  fluctuations  which may affect  reported  earnings  and
               future  cash  flows.  These  foreign  currency   conversions  are
               calculated  in  accordance  with SFAS No. 52,  "Foreign  Currency
               Translation."

               The  consolidated   financial   statements   should  be  read  in
               conjunction with the notes to the financial statements as of July
               31, 1999.

NOTE 2         The results of operations  for the three and  nine-month  periods
               ended  April  29,  2000  are not  necessarily  indicative  of the
               results to be expected for the full year.

NOTE 3         INVESTMENTS
                                                      April 29,       July 31,
                                                        2000            1999
                                                     -----------    -----------
               Deferred compensation investments     $ 1,342,602    $ 1,201,066
               Less amounts recorded as cash             (81,083)       (55,057)
                                                     -----------    -----------
                          Net                          1,261,519      1,146,009
               Other investments                          41,122        146,843
                                                     -----------    -----------
               Total                                 $ 1,302,641    $ 1,292,852
                                                     ===========    ===========

               Investments  available-for-sale  at April  29,  2000 and July 31,
               1999 include $1,342,602 and $1,201,066, respectively, for certain
               key executives' deferred compensation. At April 29, 2000 and July
               31, 1999, $81,083 and $55,057,  respectively,  were classified as
               cash and $1,261,519 and $1,146,009,  respectively,  were recorded
               as  investments.  The  liabilities of $1,342,602 and  $1,201,066,
               respectively,  are recorded as deferred  compensation  liability.
               Gains and  losses on the  investments  held to fund the  deferred
               compensation,  either  recognized  or  unrealized,  inure  to the
               benefit or detriment of the individual key  executives'  deferred
               compensation. At April 29, 2000 and July 31, 1999, the balance of
               investments   available-for-sale   of   $41,122   and   $146,843,
               respectively,  are equity  securities held by the Company for its
               own account.  Realized and  unrealized  gains and losses on these
               securities  for the periods  ended April 29, 2000 and May 1, 1999
               were not material and are recorded in the financial statements.
                                       -6-


<PAGE>



NOTE 4         PERCENTAGE OF COMPLETION ACCOUNTING
                                                       April 29,     July 31,
                                                         2000          1999
                                                      -----------   -----------

               Costs incurred on
               uncompleted contracts                  $18,610,774   $15,012,158
               Estimated earnings                      12,080,621     9,329,220
                                                      -----------   -----------
                                                       30,691,395    24,341,378
               Less billings to date                   21,017,297    17,938,846
                                                      -----------   -----------
               Costs and estimated
               earnings in excess of
               billings on uncompleted contracts      $ 9,674,098   $ 6,402,532
                                                      ===========   ===========


               The backlog of unshipped  contracts being accounted for under the
               percentage of completion  method of accounting was  approximately
               $4.9 million at April 29, 2000.

NOTE 5         INVENTORY

               Inventory is stated at the lower of cost (first-in, first-out) or
               market.

               Inventories  and their effect on cost of sales are  determined by
               physical count for annual reporting purposes and are estimated by
               management for interim reporting purposes.

               Inventory consists of the following:
                                                        April 29,    July 31,
                                                          2000         1999
                                                      -----------   -----------

               Finished goods                         $ 8,234,385   $ 5,414,095
               Work-in-process                         20,472,875    14,814,766
               Raw material and purchased parts        14,040,279    16,370,726
                                                      -----------   -----------


               Total                                  $42,747,539   $36,599,587
                                                      ===========   ===========

NOTE 6         FIXED ASSETS

               Fixed assets consist of the following:
                                                       April 29,     July 31,
                                                          2000         1999
                                                      -----------   -----------

               Land                                   $   694,046   $   694,046
               Building                                 2,200,742     2,161,025
               Machinery and equipment                 18,724,920    16,446,086
               Furniture and fixtures                   1,632,665     1,435,929
               Leasehold improvements                   2,453,593     2,180,873
               Transportation equipment                    38,495        30,103
                                                      -----------   -----------
                                                       25,744,461    22,948,062

               Less accumulated depreciation
                  and amortization                     10,059,858     8,280,002
                                                      -----------   -----------

               Net fixed assets                       $15,684,603   $14,668,060
                                                      ===========   ===========

 NOTE 7        ACQUISITION OF SUBSIDIARY

               On December  28,  1999,  the Company  obtained a 19%  interest in
               Villa  located in Milan,  Italy.  On April 3, 2000,  the  Company
               acquired an additional 61% interest to bring its total  ownership
               to 80%. The consideration paid by the Company for the acquisition
               of Villa  shares  consisted  of:  $1,100  in cash and a  six-year
               warrant to  purchase  50,000  shares of Del  Global  Technologies
               Corp.  common  stock  at the  fair  market  price  on the date of
               issuance,   valued   at   approximately   $219,000   (using   the
               Black-Scholes  method as prescribed by SFAS No. 123,  "Accounting
               for   Stock-Based   Compensation").   To  date,   the  associated
               transaction   costs  of  this  acquisition   were   approximately
               $432,000.  The source of funds for the  acquisition  of Villa was
               from the Company's working capital and  credit facility.

                                       -7-


<PAGE>




               Further,  the  Company  contributed  $1,892,000  to  the  charter
               capital of Villa. Villa management also collectively  contributed
               $108,000 to the charter capital of Villa.

               This  acquisition  is  being  accounted  for  as a  purchase  and
               accordingly,  the original purchase price was allocated to assets
               and liabilities acquired based on a preliminary estimate of their
               fair  value  at  the  date  of  acquisition  and  is  subject  to
               modification as more information becomes available.

NOTE 8         SEGMENTS

               The Company adopted SFAS No. 131,  "Disclosures about Segments of
               an Enterprise and Related Information", during the fourth quarter
               of the  year  ended  July 31,  1999.  SFAS  No.  131  establishes
               standards for reporting  information about operating  segments in
               annual  financial  statements and requires  selected  information
               about operating segments in interim financial statements. It also
               establishes  standards for related disclosures about products and
               services,   major  customers  and  geographic  areas.   Operating
               segments are defined as components  of an enterprise  about which
               separate  financial  information  is available  that is evaluated
               regularly by the chief decision  maker, or decision making group,
               in  deciding   how  to  allocate   resources   and  in  assessing
               performance.  The Company's chief operating decision making group
               is  comprised  of the  Chief  Executive  Officer  and the  senior
               executives of the Company's operating segments.

               The Company has two reportable segments which are Medical Imaging
               Systems and Critical Electronic  Subsystems.  The Medical Imaging
               Systems    Segment    designs,     manufactures    and    markets
               state-of-the-art,  cost-effective  medical imaging and diagnostic
               systems  consisting of stationary and portable  imaging  systems,
               radiographic/fluoroscopic   systems,   mammography   systems,   a
               neo-natal imaging system and dental imaging systems. The Critical
               Electronic  Subsystems Segment designs,  manufactures and markets
               proprietary  precision  power  conversion  and  electronic  noise
               suppression subsystems for medical as well as critical industrial
               applications.

               Selected financial data of these segments is as follows:

                                         Medical      Critical
                                         Imaging     Electronic
                                         Systems     Subsystems       Total
                                       -----------   -----------    ------------
               For the Nine Months
               Ended April 29, 2000:

               Net sales to external
                  customers            $30,444,207   $23,244,364    $ 53,688,571
                                       ===========   ===========    ============
               Income before provision
                  for income taxes     $ 3,048,928   $ 4,511,585    $  7,560,513
                                       ===========   ===========    ============

               Segment assets          $54,123,525   $53,085,804    $107,209,329
                                       ===========   ===========    ============


                                         Medical      Critical
                                         Imaging     Electronic
                                         Systems     Subsystems       Total
                                       -----------   -----------   ------------
               For the Nine Months
               Ended May 1, 1999:

               Net sales to external
                  customers            $27,071,278    $22,344,865    $49,416,143
                                       ===========    ===========    ===========
               Income before provision
                  for income taxes     $ 2,947,878    $ 4,019,557    $ 6,967,435
                                       ===========    ===========    ===========

               Segment assets          $37,490,805    $44,746,864    $82,237,669
                                       ===========    ===========    ===========



                                       -8-


<PAGE>



NOTE 9         COMPREHENSIVE INCOME

               The Company's total comprehensive income was as follows:

                                                     Three Months    Nine Months
                                                        Ended           Ended
                                                       April 29,      April 29,
                                                         2000           2000
                                                     -----------    -----------


               Net Income                            $ 1,923,852    $ 5,217,993
               Change in equity due to foreign
                currency translation adjustments          (8,091)        (8,091)
                                                     -----------    -----------
               Comprehensive income                  $ 1,915,731    $ 5,209,902
                                                     ===========    ===========



                                       -9-


<PAGE>



Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
         -----------------------------------------------------------
         AND RESULTS OF OPERATIONS

This  Management  Discussion and Analysis of Financial  Condition and Results of
Operations contains forward looking statements.  Such statements involve various
risks that may cause actual results to differ  materially.  These risks include,
but are not  limited to, the  ability of the  Company to grow  internally  or by
acquisition  and  to  integrate  acquired   businesses,   changing  industry  or
competitive   conditions,   and  other  risks   referred  to  in  the  Company's
registration  statements  and periodic  reports  filed with the  Securities  and
Exchange Commission.

OVERVIEW

                 The  Company's  net sales  have  increased  as a result of both
internal growth and acquisitions.  The Company has completed six acquisitions in
the past eight years:  Dynarad (a designer and  manufacturer  of medical imaging
systems and critical  electronic  subsystems) in fiscal 1993; Bertan (a designer
and  manufacturer  of precision high voltage power supplies and  instrumentation
for  medical  and  industrial   applications)  in  fiscal  1994;  Gendex-Del  (a
manufacturer of medical  imaging  systems) in fiscal 1996;  X-Ray  Technologies,
Inc. (a manufacturer of medical imaging  systems) in fiscal 1998,  Acoma Medical
Imaging Inc. (a designer and  manufacturer of medical imaging systems) in fiscal
1999 and Villa Sistemi  Medicali S.p.A. (a designer and  manufacturer of medical
and dental imaging systems) in fiscal 2000.

                 During the past five years the Company has grown internally and
through  acquisitions into a company whose  predominant  business is serving the
medical imaging and diagnostic markets.  The Company's net sales attributable to
medical imaging products have increased from approximately  $14.4 million or 44%
of total net sales in fiscal 1995 to approximately $49.2 million or 72% of total
net sales in fiscal 1999.

                 Management  believes that recent cost containment trends in the
healthcare  industry have created  opportunities for its cost-effective  medical
imaging products in domestic and international markets. Some of these trends are
increased  demand for lower cost medical  equipment,  the outsourcing of systems
and critical electronic  subsystems by leading original equipment  manufacturers
("OEMs"),  increased  demand for certain  diagnostic  procedures  and lower cost
medical services in the global marketplace.

RESULTS OF OPERATIONS

                 Net sales  for the  three  months  ended  April  29,  2000 were
approximately  $20.5 million as compared to approximately  $18.7 million for the
three  months  ended May 1, 1999,  an  increase  of 10%.  Net sales for the nine
months  ended April 29,  2000 were  approximately  $53.7  million as compared to
approximately  $49.4  million for the nine months ended May 1, 1999, an increase
of 9%.  These  increases  are  primarily  due to internal  growth from  existing
operations.

                 Cost of  sales,  as a  percentage  of net  sales  for the three
months  ended  April  29,  2000,  was  61% as  compared  to 60%  for  the  prior
corresponding  period.  Cost of sales, as a percentage of net sales for the nine
months  ended  April  29,  2000,  was  60% as  compared  to 59%  for  the  prior
corresponding period. These increases are due to a change in product mix in both
periods.

                 Research and development  expenses were  approximately $2.1 and
$1.8 million for the three- month  periods ended April 29, 2000 and May 1, 1999,
respectively, an increase of 17%. Research and development expenses increased to
approximately  $5.3  million  for the nine  months  ended  April  29,  2000 from
approximately $4.7 million for the nine months ended May 1, 1999, an increase of
13%. This increase was  primarily  due to new product  development.  The Company
continues  to invest in  research  and  development  in order to  introduce  new
state-of-the-art products for its medical and industrial markets.

                 Selling, general and administrative expenses were approximately
$3.0 million and $3.1 million for  three-month  periods ended April 29, 2000 and
May 1, 1999,  respectively,  or 14.6% and 16.4% of net sales,  due to  increased
sales volume.  Selling,  general and administrative  expenses were approximately
$8.3 million,

                                      -10-


<PAGE>



or 15.5% of net sales,  for the nine months  ended April 29, 2000 as compared to
approximately  $8.4  million,  or 17.1% of net  sales,  due to  increased  sales
volume, for the same period in the prior year.

                 Net interest expense was  approximately  $129,000 for the three
months  ended  April 29,  2000 as  compared  to  approximately  $79,000  for the
corresponding  period in the prior year. Net interest expense was  approximately
$274,000 for the nine months  ended April 29, 2000 as compared to  approximately
$101,000 for the corresponding period in the prior year. These increases are due
to higher interest rates and higher levels of debt for both periods.

                 Income tax expense was 30.4% of pretax income for the three and
nine months ended April 29, 2000 and 31% for the three and nine months ended May
1, 1999. The decrease from statutory  rates is primarily due to sales being made
through the Company's  Foreign Sales  Corporation,  research and development and
other tax credits.

                 Net income  increased  to  approximately  $1.9  million for the
three months ended April 29, 2000, an increase of 8.5% from  approximately  $1.8
million for the prior  corresponding  period.  Basic earnings per share at April
29, 2000  increased to $.25 from $.23 at May 1, 1999, an increase of 9%. Diluted
earnings per share increased to $.24 at April 29, 2000 from $.22 at May 1, 1999,
an increase of 9%. The weighted number of common shares outstanding increased to
7,824,196  at April 29,  2000 from  7,700,294  at May 1, 1999 and the  number of
common shares and common share equivalents outstanding increased to 8,175,899 at
April  29,  2000  from  8,163,269  at May  1,  1999.  Net  income  increased  to
approximately $5.2 million for the nine months ended April 29, 2000, an increase
of 9% from approximately $4.8 million for the prior corresponding  period. Basic
earnings per share at April 29, 2000 increased to $.67 from $.63 at May 1, 1999,
an increase of 6%.  Diluted  earnings  per share  increased to $.64 at April 29,
2000 from $.59 at May 1, 1999, an increase of 9%. The weighted  number of common
shares  outstanding  increased to 7,807,739 at April 29, 2000 from  7,658,666 at
May 1,  1999 and the  number of  common  shares  and  common  share  equivalents
outstanding  increased to  8,170,552 at April 29, 2000 from  8,163,470 at May 1,
1999.  These  increases  in net  income  for both the three  and the  nine-month
periods ended April 29, 2000 were due to higher sales.

                 The  backlog  of  unshipped   orders  at  April  29,  2000  was
approximately $47 million.

LIQUIDITY AND CAPITAL RESOURCES

                 The Company has funded its operations and acquisitions  through
a combination of cash flow from operations,  bank borrowings and the issuance of
the Company's common stock.

                 Working  Capital.  At April  29,  2000 and July 31,  1999,  the
Company's  working  capital was  approximately  $56.1 million and $47.8 million,
respectively.  At such dates the  Company  had  approximately  $1.2  million and
$321,000, respectively, in cash and cash equivalents.

                 Cost  and   estimated   earnings   in  excess  of  billings  on
uncompleted  contracts increased to approximately $9.7 million at April 29, 2000
from  approximately  $6.4 million at July 31, 1999, due to additional  long-term
contracts  accounted for under the percentage of completion method of accounting
in the nine-month period.

                 Trade receivables increased approximately $8.1 million at April
29, 2000 as compared to July 31, 1999 primarily due to the  acquisition of Villa
and higher sales in the period.

                 Inventory  at  April  29,  2000  increased  approximately  $6.1
million as compared to July 31, 1999  primarily  because of the  acquisition  of
Villa and higher sales levels of major medical OEM contracts.

                 Prepaid  expenses  and other  current  assets at April 29, 2000
increased  approximately  $1.4  million as compared  to July 31, 1999  primarily
because of the acquisition of Villa and increased prepaid trade show expense.

                                      -11-


<PAGE>



                 Goodwill increased approximately $2.3 million at April 29, 2000
as compared to July 31, 1999 because of the acquisition of Villa.

                 On December  28, 1999,  the Company  obtained a 19% interest in
Villa Sistemi  Medicali S.p.A.  ("Villa")  located in Milan,  Italy, On April 3,
2000,  the  Company  acquired  an  additional  61%  interest  to bring its total
ownership to 80%. The  consideration  paid by the Company for the acquisition of
Villa shares  consisted  of:  $1,100 in cash and a six-year  warrant to purchase
50,000 shares of Del Global  Technologies  Corp. common stock at the fair market
price on the date of  issuance  valued  at  approximately  $219,000  (using  the
Black-Scholes  method as prescribed by SFAS No. 123, "Accounting for Stock-Based
Compensation").  To date, the associated  transaction  costs of this acquisition
were  approximately  $432,000.  The source of funds for the acquisition of Villa
was from the Company's working capital and credit facility.

                 Accounts payable increased  approximately $4.9 million at April
29, 2000 from July 31, 1999 due to the acquisition of Villa.

                 Credit  Facility and  Borrowing.  At April 29, 2000 the Company
had a $14.0 million revolving credit line and a $10.0 million acquisition credit
line with its bank.  The  available  portion of the  revolving  credit  line was
approximately  $8.4 million,  after deducting  outstanding  letters of credit of
approximately  $1.6 million and $7.5 million was available under its acquisition
credit line. Additionally, Villa has a revolving line of credit of approximately
$9.2  million with a consortium  of banks which is used  primarily  for accounts
receivable  financing.  At April 29, 2000,  approximately $3.8 million was being
utilized.
                 Long-term debt increased approximately $4.3 million as compared
to  July  31,  1999,  primarily  due to the  acquisition  of  Villa,  additional
investments in capital equipment and additional working capital requirements. In
addition,  Villa has a term loan of approximately  $412,000 with its bank and an
Italian government research and development loan of approximately $1.6 million.

                 The Company anticipates that cash generated from operations and
amounts  available  under its bank  lending  facilities  will be  sufficient  to
satisfy its currently projected operating cash needs.

                 Capital  Expenditures.  The  Company  continues  to  invest  in
capital  equipment,  principally for its manufacturing  operations,  in order to
improve its  manufacturing  capability  and  capacity.  The Company has expended
approximately $2.4 million for capital equipment for the nine-month period ended
April 29, 2000.

                 Shareholders'   Equity.   Shareholders'   equity  increased  to
approximately  $71.7 million at April 29, 2000 from approximately  $66.4 million
at July 31,  1999,  primarily  due to the results of  operations.  Additionally,
during the current nine-month period 117,738 stock options were exercised,  with
proceeds of $248,133  and 81,953  shares of common stock were  repurchased  at a
cost of approximately $659,000.

EFFECTS OF NEW ACCOUNTING PRONOUNCEMENTS

                 Disclosures   about   Derivative    Instruments   and   Hedging
Activities.  In June  1998,  the FASB  issued  SFAS  No.  133,  "Accounting  for
Derivative  Instruments  and  Hedging  Activities."  SFAS  No.  133  establishes
accounting  and  reporting  standards  for  derivative  instruments  and hedging
activities.  SFAS No. 133 is  effective  for all fiscal  quarters  of all fiscal
years beginning after June 15, 2000. Due to the acquisition of the  consolidated
foreign  subsidiary of Villa,  management is currently  evaluating  the possible
affects of this  statement  on the future  results  of the  Company's  financial
position,  future  results of its  operations  and future cash flows.  Since the
Company does not engage in derivative  instrument  activity,  this pronouncement
has no current affect on its financial statements.

Item 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
         ----------------------------------------------------------

                 None.


                                      -12-


<PAGE>



                                     PART II

Item 1.        Legal Proceedings

                    None

Item 2.        Changes in Securities

                    None

Item 3.        Defaults on Senior Securities

                    None

Item 4.        Submission to a Vote of Security Holders

                    None

Item 5.        Other Information

                    None

Item 6.        Exhibits and Reports on Form 8-K

               (a)  Exhibits:  Exhibit 11  -  Computation of Earnings per Common
                                              Share
                               Exhibit 27  -  Financial Data Schedule

               (b)  Report on Form 8-K     -  Filed May 5, 2000
























                                      -13-


<PAGE>



                                   SIGNATURES

        Pursuant to the requirements of the Securities and Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                          DEL GLOBAL TECHNOLOGIES CORP.
                                          -----------------------------



                                                       /S/LEONARD A. TRUGMAN
                                                       ---------------------
                                                       Leonard A. Trugman
                                                       Chairman of the Board,
                                                       Chief Executive Officer
                                                       and President




                                                       /S/MICHAEL H. TABER
                                                       ---------------------
                                                       Michael H. Taber
                                                       Chief Financial Officer,
                                                       Vice President of Finance
                                                       and Secretary



Dated: June 16, 2000







                                      -14-